BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9266849)

  • 1. ATF-like element contributes to hepatic activation of human angiotensinogen promoter.
    Yanai K; Murakami K; Fukamizu A
    Biochem Biophys Res Commun; 1997 Aug; 237(1):158-62. PubMed ID: 9266849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DBP binds to the proximal promoter and regulates liver-specific expression of the human angiotensinogen gene.
    Narayanan CS; Cui Y; Kumar A
    Biochem Biophys Res Commun; 1998 Oct; 251(1):388-93. PubMed ID: 9790965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of transcriptional activation of angiotensinogen gene by proximal promoter.
    Tamura K; Umemura S; Ishii M; Tanimoto K; Murakami K; Fukamizu A
    J Clin Invest; 1994 Apr; 93(4):1370-9. PubMed ID: 8163641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2.
    Kim SJ; Wagner S; Liu F; O'Reilly MA; Robbins PD; Green MR
    Nature; 1992 Jul; 358(6384):331-4. PubMed ID: 1641004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activity.
    Wang HH; Chiang AN
    Biochem J; 2004 Jun; 380(Pt 2):455-63. PubMed ID: 14984368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple CCAAT binding proteins regulate the expression of the angiotensinogen gene.
    Zhao YY; Qasba P; Siddiqui MA; Kumar A
    Cell Mol Biol Res; 1993; 39(8):727-37. PubMed ID: 7951412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ATF/CREB site is the key element for transcription of the human RNA methyltransferase like 1(RNMTL1) gene, a newly discovered 17p13.3 gene.
    Xu J; De Zhu J; Ni M; Wan F; Gu JR
    Cell Res; 2002 Sep; 12(3-4):177-97. PubMed ID: 12296377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a second ATF/CREB-like element in the herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) promoter.
    Kenny JJ; Krebs FC; Hartle HT; Gartner AE; Chatton B; Leiden JM; Hoeffler JP; Weber PC; Wigdahl B
    Virology; 1994 Apr; 200(1):220-35. PubMed ID: 8128624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cell type-dependent enhancer core element is located in exon 5 of the human angiotensinogen gene.
    Nibu Y; Tanimoto K; Takahashi S; Ono H; Murakami K; Fukamizu A
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1102-8. PubMed ID: 7802638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site.
    Nakamura T; Okuyama S; Okamoto S; Nakajima T; Sekiya S; Oda K
    Exp Cell Res; 1995 Feb; 216(2):422-30. PubMed ID: 7843287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MyoD transactivates angiotensinogen promoter in fibroblast C3H10T1/2 cells.
    Goswami SK; Zhao YY; Siddiqui MA; Kumar A
    Cell Mol Biol Res; 1993; 39(2):125-30. PubMed ID: 8220582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of HNF1alpha, HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation.
    Lin B; Morris DW; Chou JY
    Biochemistry; 1997 Nov; 36(46):14096-106. PubMed ID: 9369482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation.
    Kirch HC; PĆ¼tzer B; Schwabe G; Gnauck HK; Schulte Holthausen H
    Cell Mol Biol Res; 1993; 39(8):705-16. PubMed ID: 7951410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cAMP increases the expression of human angiotensinogen gene through a combination of cyclic AMP responsive element binding protein and a liver specific transcription factor.
    Narayanan CS; Cui Y; Kumar S; Kumar A
    Mol Cell Biochem; 2000 Sep; 212(1-2):81-90. PubMed ID: 11108139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of peroxisome proliferator-activated receptor alpha on human angiotensinogen promoter.
    Shimamoto Y; Hirota K; Fukamizu A
    Int J Mol Med; 2004 May; 13(5):729-33. PubMed ID: 15067378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nuclear receptor, hepatocyte nuclear factor 4, differently contributes to the human and mouse angiotensinogen promoter activities.
    Oishi T; Date S; Shimamoto Y; Saito T; Hirota K; Sugaya T; Kon Y; Fukamizu A; Tanimoto K
    J Recept Signal Transduct Res; 2010 Dec; 30(6):484-92. PubMed ID: 20684663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orphan receptor Arp-1 binds to the nucleotide sequence located between TATA box and transcriptional initiation site of the human angiotensinogen gene and reduces estrogen induced promoter activity.
    Narayanan CS; Cui Y; Zhao YY; Zhou J; Kumar A
    Mol Cell Endocrinol; 1999 Feb; 148(1-2):79-86. PubMed ID: 10221773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene.
    Yanai K; Nibu Y; Murakami K; Fukamizu A
    J Biol Chem; 1996 Jul; 271(27):15981-6. PubMed ID: 8663141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cis-acting DNA elements involved in the regulation of angiotensinogen gene expression.
    Zhao YY; Gu W; Siddiqui MA; Kumar A
    Cell Mol Biol; 1992 Feb; 38(1):71-80. PubMed ID: 1559246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ATF/CREB site is the major regulatory element in the human herpesvirus 6 DNA polymerase promoter.
    Agulnick AD; Thompson JR; Ricciardi RP
    J Virol; 1994 May; 68(5):2970-7. PubMed ID: 8151767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.